Benzinga | Nov 9, 2020 04:13PM EST

Evofem Biosciences Q3 EPS $(0.37) Beats $(0.44) Estimate, Sales $278.00K May Not Compare To $1.72M Estimate

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.44) by 15.91 percent. This is a 23.33 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $278.00 thousand which missed the analyst consensus estimate of $1.72 million by 83.84 percent.